CDC monitoring cases of drug-resistant ringworm
Two cases of a highly contagious and drug-resistant strain of ringworm have been reported in New York City, leading to concerns among health officials.
The CDC (Centers for Disease Control and Prevention) is closely monitoring the situation as more doctors observe patients taking longer to respond to medications for the infection.
Ringworm, contrary to popular belief, is not caused by a fungus.
However, this was not the case in the two reported cases in New York City.
The affected individuals were advised not to use creams and instead required weeks of antifungal medication to clear their infections.
The situation raises questions about how this drug-resistant strain emerged and the potential for it to spread to the general public.
One patient developed the rash while traveling in South Asia, an area where fungal infections have become resistant to most drugs.
This resistance is similar to what has been observed with antibiotic resistance, where overuse of drugs leads to decreased effectiveness over time.
According to a dermatologist in New York City, there is currently no threat to the general public.
However, it is important to be aware of the symptoms of ringworm, which include an extremely itchy red rash that is circular in shape, often with a clear center.
The rash can appear anywhere on the body, including the scalp.
If individuals suspect they have ringworm, they are advised to contact a dermatologist rather than attempting to treat it with over-the-counter creams, as self-medication may worsen the problem.
It is also crucial to keep the affected area dry, as ringworm spreads easily, even through bed linens.
The CDC’s monitoring efforts aim to contain the spread of this drug-resistant strain of ringworm and ensure appropriate treatment options are available.
Health officials and medical professionals are working together to address the situation and provide guidance to individuals affected by this concerning development.